




版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡介
外科學(xué)與免疫學(xué)
Surgery&Immunology
基本概念
BasicPrinciples
概念Concepts
免疫:Immune:免除傳染protectfrompathogens
免疫性Immunity:抗感染的能力Capacityofdefenseinfection
免疫應(yīng)答Immuneresponse:responseofrecognitionandeliminationantigenicityforeign
material
免疫學(xué)Immunology:Thesciencestudyonthestructure&functionoftheimmunesystem
Scienceofself-nonselfdiscrimination
天然免疫與獲得性免疫
AdaptiveandInnateimmunity
天然免疫
機(jī)體與生具有的抵抗外來病原的防御系統(tǒng)
無特異性,包括Includingbarriers,Basicbarrier:skin,mucosa.Physicalbarrier:bodytemp,ph
Phagocytes,Inflammation
AdaptiveorSpecificImmuneresponse
Highlyspecificforaparticularpathogen
Specific
Muti-type
Remember/memory
Transferable
免疫應(yīng)答的三個(gè)時(shí)相Threephasesofimmuneresponse
Recognition:Agrecognizedbylymphocytes
Activation:lymphocytesactivation
Response:LymphocytescoordinateanimmuneresponsethateliminatesthesourceoftheAg
免疫系統(tǒng)ImmuneSystem
OrgansoftheImmuneSystem免疫器官
CellsoftheImmuneSystem免疫細(xì)胞
MoleculeoftheImmuneSystem免疫分子
LymphoidTissues
Primarylymphoidorgans
Thymus------Tcellmature
fetalliver
Bonemarrow
Secondarylymphoidorgansandtissues
Spleen
lymphnodesandlymphaticsystem
Mucosa-associatedlymphoidtissue(MALT)
CellsoftheInnateImmuneSystem
Phagocytes
Mononuclearphagocytes
Polymorphs
Neutrophils
Eosinophils
Basophilsandmastcells
Platelets
Naturalkiller(NK)cells
CellsoftheAdaptiveImmuneSystem
Lymphocytes
Tcells,a3TY5TSuppressorT
Bcells
Antigen-presentingcells(APCs)
Moleculesofimmunesys
immunoglobulin/BCR
TCR
complement
cytokines
adhesionmolecules
MHC
TCR
TheaBTCRheterodimerformstherecognitionunitofthereceptor
CD3complexassociateswiththeapandY5formsoftheTCR
MHC
MHCImoleculesconsistofanMHC-encodedheavychainboundtoB2-microglobalin
B2-MisessentialforexpressionofMHCImolecules
Heavychainax&a2domainsformtheAg-bindinggroove
Variationsinaasequencechangetheshapeofthebindinggroove
MHCIIblindinggrooveaccommodatelongerpeptidesthanclassI
PeptidesareheldintheMHCmoleculesbindingcleftbycharacteristicanchorresidues
Antigenpresentation抗原遞呈
Tcellsrecognizepeptidefragmentswhichhavebeenprocessed
T細(xì)胞識別的是經(jīng)過加工過的多肽片段
InteractionwithAPCisessentialforT-cellactivation
APC-T細(xì)胞之間的相互作用是T細(xì)胞激活所必須
AntigenProcessingandPresentation抗原加工與遞呈
AgsareprocessedbeforetheyarepresentedtoTcells
抗原遞呈給T細(xì)胞之前須加工
AgsarepartiallydegradedintopeptidebeforebindingtoMHCmolecules
抗原在與MHC分子結(jié)合之前被降解成抗原肽
ClassImoleculesassociatewithendogenouslysynthesizedpeptides
I類分子與內(nèi)原性合成多肽相關(guān)
Proteasomesarecytoplasmicorganellesthatdegradecytoplasmicproteins
蛋白酶體是胞質(zhì)匈胞器以降解胞內(nèi)蛋白
ClassIImoleculesareloadedwithexogenouspeptidesinanendosomalcompartment
II類分子在包涵體內(nèi)負(fù)載外原性抗原多肽
TwopathwaysofproteinAgprocessing&presentation蛋白質(zhì)抗原加工遞呈的兩類途徑
AgTypeExampleEnzymesMHCSiteCellPathway
ExogenousBacteriaEndosomeIILysomeCD4+Endocytosis
內(nèi)原性細(xì)菌包涵體溶酶體胞吞
EndogenousVirusesPeoteasomeIERCD8+Cytosolic
外原性病毒蛋白酶體內(nèi)質(zhì)網(wǎng)麗質(zhì)溶解
MainmoleculesassociatedwithTcellactivation
MHC-Pep-TCRtri-molecularcomplex
TCR-CD3complex
CD4/CD8co-receptor
CD45
CD28
LFA1/ICAM1,CD2/LFA3
TcellActivation
3signals:recognition,activation,growth
3receptor-ligants:Pep-TCR,B7-CD28,IL2-IL2R
3results:surfacemoleculesexpression,cytokinessynthesisandsecretion,
TcellcloningformingandampliHcation
Cell-mediatedcytotoxicity
CytotoxicTcellsrecognizeAgpresentedonMHCmolecules
NKcellsreactagainstcellswhichdonotexpressMHC-I
NKcellsexpresstwomajorclassesofinhibitoryreceptorsforMHCmolecules
Cytotoxicityismediatedbycombinationsofdirectcell-cellinteractions,cytokinesandthe
releaseofgranuleproteins
LigationofFasorthetype-1TNF-Ronthetargetcellleadstotheactivationofcaspases
Myeloidcellsinducedamageintargetsprincipallybythereleaseoftoxicmolecules
Mechanismsofcytotoxicity
Cytotoxicityiseffectedbydirectcellularinteraction,cytokinesandgranuleexocytosis
CytotoxicTcellsandNKcellsinduceapoptosisintheirtargets
Caspasesmediatecelldeathbyapoptosis
CytotoxicitymaybesignalledviaFasoraTNFreceptoronatargetcell
GranulesofcytotoxicTcellscontainperforinandgranzymes
ImmuneResponse
Antibody
Neutralization
Complementdependentcytotoxicity(CDC)IgQIgM
Abdependentcellmediatedcytotoxicity(ADCC)IgG
Tcell
Granuleexocytosis:profin,granzyme
Apoptosis:Fas-FasL,
NKandM6
NK:sameasCTL:Granuleexocytosis,Apoptosis
NK&M:ADCC
M6:directkill:releaselysomalenzymes
inhibitDNA,RNA,andPro.synthesis
Cytokine
Lymphocytesdifferentiationandmaturation
Enhancemoleculesexpressiononlymphocytes
Directtoxicity
Anti-viruses
Immunitytoviruses病毒免疫
Virusesareobligateintracellularparasites
病毒是專性胞內(nèi)寄生物
Viruseshaveevolvedstrategiestoavoidrecognitionbythehost
病毒通過進(jìn)化以逃避宿主識別
Virusesmaydirectlydisruptthefunctionoftheimmunesystem
病毒可以直接破壞免疫系統(tǒng)功能
Innateimmuneresponsetoviruses
天然免疫
Initialdefence:Integrityofthebodysurface
初始抵御:機(jī)體表面的完整性
IFNstimulatesinhibitionofviralreplication
IFN刺激抑制病毒復(fù)制
NKcellsarecytotoxicforvirallyinfectedcells
NK細(xì)胞對被麻染細(xì)胞的細(xì)胞毒作用
Macrophagesbecomeactive
巨嗜細(xì)胞的活化
Adaptiveimmuneresponse獲得性免疫應(yīng)答
Antibodyandcomplementcanlimitviralspreadorre-infectionAb和補(bǔ)體限制病毒播散或再感
染
Antibodycanneutralizetheinfectivityofviruses
Ab中和病毒
complementsininvolvedintheneutralizationofsomefreeviruses
補(bǔ)體中和一些游離病毒
Absmobilizecomplement&/oreffectcellstodestroyvirus-infectedcells
Ab動員補(bǔ)體和/或效應(yīng)性細(xì)胞殺傷病毒感染的細(xì)胞"
Adaptiveimmuneresponse
獲得性免疫應(yīng)答
Tcellmediateviralimmunityinseveralways
T細(xì)胞介導(dǎo)的抗病毒免疫
MostoftheAbresponseisthymusdependent,requiringthepresenceofCD4+Tcellsforclass
switchingandaffinitymaturation.
抗體應(yīng)答須要有CD4+T的輔助
CD4+TcellsalsohelpintheinductionofCD8+CTL
CD4+T還可以輔助誘導(dǎo)CD8+CTL
CD4+Tintherecruitmentandactivationofmacrophagesatsitesofvirusinfection
CD4+T在病毒感染部位可募集和激活巨嗜細(xì)胞
CD8+Tcellsarealsoeffectiveinpreventionofre-infection.
CD8+T可有效地防止再感染
TumorImmunology
Immunesurveillance
免疫監(jiān)視
Immunesurveillanceisaconceptthatenvisagespreventionofthedevelopmentofmosttumors
throughearlvdestructionofabnormalcellsbythehosfsimmunesys
機(jī)體免疫系統(tǒng)可以發(fā)揮免疫監(jiān)視作用,識別并消滅任何表達(dá)新抗原的“異己”成分或突變細(xì)胞,
以保持機(jī)體內(nèi)環(huán)境的穩(wěn)定
Surveillanceismosteffectiveagainstvirusesnottumorcells
Immunesurveillance免疫監(jiān)視的證據(jù)
ostmortemdatasuggestthattheremaybemoretumorsthanbecomeclinicallyapparent
尸檢資料顯示腫瘤實(shí)際發(fā)生率高于臨床發(fā)現(xiàn)
Manytumorscontainlymphoidinfiltratesandinsometumorsthismaybefavorablesign
許多沛瘤有淋巴細(xì)胞浸潤,在某些腫瘤是預(yù)后好的征象
Spontaneousregressionoftumoroccurred
有腫瘤自行消退的現(xiàn)象
Ttimorsoccurredmorefrequentlyintheneonatalperiodandinoldage,whentheimmunesys
functionslesseffectively
免疫功能低下狀態(tài)腫描更易發(fā)生
Tumorsarisefrequentlyinimmunosuppressedindividuals
免疫抑制狀態(tài)腫瘤發(fā)生率高
Tlimorantigens-Classification
ClassIHLA-restrictedcancer/testisAgs
ClassIHLA-restricteddifferentiationAgs
ClassIHLA-restrictedwidelyexpressedAgs
ClassIHLA-restrictedtumorspecificAgs
ClassIIHLA-restrictedtumorAgs
Fusionproteins
Tumorantigens腫瘤抗原特性
TiimorAgsmaybedetectedbyimmunecellsorAbs
腫瘤抗原可被T細(xì)胞或抗體所檢測
SharedtumorAgsareviralorigin
腫瘤共有抗原通常為病毒原性
TumorspecifictransplantationAgsareduetoalterationsintumorgenesorgeneexpression
腫瘤特異性抗原通常是腫瘤基因改變后表達(dá)產(chǎn)物
Antigenname(s)TumourtypesNormaltissue
distribution
Cancer/testisAgs
MAGE1SomemelanomasTestis
MAGE3andothertumour
BAGEtypes
GAGE
MelanocytediffAgs
MelanA/MART-1MelanomaNormal
Tyrosinasemelanocytes
gp100/Pmel17
gp75/TRP-l
DiffAgsofother
PSAProstateProstate
CEAColonandotherColon
carcinomas
MutatedAgs
MutatedrasManycarcinomasNotpresent
Her-2/neuBreastandovaryNotpresent
NameSourcecDNAlibrary
CancertestisAgs
HOM-Mel-40Melanoma
NY-ESO-1Melanoma
MAGE1Melanoma
DifTAgs
TyrosinaseMelanoma
Galectin-9Hodgkin'sdisease
CarbonicanhydraseRenalcarcinoma
Housekeepinggenes
PCNAMelanoma
EndogenousretroviralgenesMelanoma
HERV-K10
MutatedAgs
p53(mutated)Coloncarcinoma
Active
non-specificBCG,Corynebacteriumparvum,
levamisole,cytokines
specificTherapeuticvaccinesoftumourcells,
cellextracts,purifiedorrecombinant
antigens,peptides,heatshockproteins
orDNAantigen-pulseddendriticcells
Passive
non-specificLAKcells
specificAntibodiesaloneorcoupledtoddrugs,
pro-drugs,toxinsorradioiisotope,
bi-specificantibodiesTcells
CombinedLAKcellsandbi-specificantibody
Immunotherapy免疫治療策略
?ImmunizationwithtumorAgs腫瘤抗原免疫
?Immunizationwithdendriticcells樹突狀細(xì)胞免疫
?Non-specificstimulationofimmuneresponses非特異性免疫
?Immunotherapywithcytokinecancausetumorregression細(xì)胞因子免疫治療
?Immunizationwithoncogenicviruses腫瘤性病毒
PassiveImmunotherapy過繼性免疫治療
TherapywithLAKcells
ImmunotherapywithTcells
Therapywithantibodies
TiimourTargetantigenImmunization
BreastMUC1SialylTNAg-KLHconjugatewithadjuvant
RecombinantVaccinia-MUC1viruswithIL-2
CervixHPVE6/E7RecombinantVacciniaHPVE6/E7
RecombinantE6/E7protein
Syntheticpeptidesinadjuvant
LymphomaIgRecombinantprotein
idiotypeIdiotypesinglechainFv-toxoidDNAconstruct
DCpulsedwithidiotypicprotein
MelanomaVariousAllogeneicwholecells,cellstrasducedwithCK,
Peptides,DC/peptidesorDC/tumorlysate
ProstatePSALiposomeencapsulatedPSA,DC/peptides
GloboHSyntheticAg-KLHconjugatewithQS21
hexasaccharideadjuvant
TypeofBRMexamplesmajoreffect
bacterialproductsBCGC.parvum,activateM小NK
muramyldipeptide
trehalosedimycolate
Syntheticpyrancopolymer,induceIFNprod.
moleculesMVE,polyI:C,
pyrimidines
CytokinesIFNaBY,activateM6NK
IL-2,TNF
Hormonesthymosin,thymulin,modulate
thymopoietinT-cellfunctioin
Cytokinetumourtypecytokineeffectsandpossible
andresultsanti-tumourmechanisms
IFNaprolongedremissionspossiblecytostatic
ofhairy-cellleukaemiaeffectontumour
weakeffectsonincreasedexpressionof
somecarcinomasMHCclassI,cytostasis
IFNTineffectivesystemically,increasedMHCclassIandII
remissionsofperitonealmacrophageactivation
carcinomaoftheovaryTcactivation,cytostasis
IL-2remissionsinrenalT-cellactivation
cancerandmelanomaandproliferation
NK-cellactivation
TNFacanreduce?increasedtumour
malignantascitescelladhesion,
macrophageand
lymphocyteactivation
Obstaclestotumorimmunity
Self-originoftumorantigens
?Mostproteinsthatareexpressedbytumorcellsarerecognizedbytheimmunesystemas
self-antigens.
?Theestablishmentoftumorimmunitycanthereforebeconstruedasanattempttoinduce
autoimmunity.Immunemechanismsthathaveevolvedtoavoidautoimmunity,suchas
immunologicalignorance,clonaldeletionandanergy,thereforehampertheantitumorresponse
Antigenloss
?Tumorcellscandovvn-regulatetheexpressionofantigensthatarerecognizedbytheimmune
system.ThisabilitytoMmmuno-ediftumorantigenprofilesunderscorestheimportanceof
directingTcellsagainstmultipletumorantigens.
Down-regulationofHLAexpression
?Tumorcellscanalsodown-regulatetheexpressionofHLAclassI
ResistancetoCTLs
?Tcellsexpresscytolyticandapoptosis-inducingmoleculessuchasFASL,TNF-a,perforinand
granzyme.Tumouscandown-regulatethereceptorsorthedownstreamsignalsthatare
activatedbythesemoleculestoevadeCTLinducedcelldeath
Environmentalsuppression
?Tiimorsmightsecreteorexpressmoleculesontheircellsurfacethatinhibittheimmune
responseandeventuallyimpairsignalinginTcells
TheFRESHcriteriaforexpandingantitumorTcells
Function
?Thepreservationofantigenspecificityandcytolyticactivitymustbeenforcedthroughout
expansion.Thiscanrequireoptimizedantigenpresentationand/orT-cellpurification.
Remanence
?Thegenerationoflong-lastingimmunologicalmemoryisanimport
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫網(wǎng)僅提供信息存儲空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。
最新文檔
- 國際公路建設(shè)標(biāo)準(zhǔn)與比較試題及答案
- 行政管理理論的多維度思考試題及答案
- 科教興國政策的未來走向試題及答案
- 2025年信息系統(tǒng)項(xiàng)目管理師行業(yè)動態(tài)分析試題及答案
- 2025年軟件設(shè)計(jì)師考試關(guān)鍵技能試題及答案
- 信息系統(tǒng)風(fēng)險(xiǎn)控制做法2025年試題及答案
- 實(shí)現(xiàn)高分的公路工程考試策略與試題及答案
- 行政組織中的創(chuàng)新型思維試題及答案
- 公路工程競爭優(yōu)勢分析試題及答案
- 行政組織理論的系統(tǒng)思維試題及答案
- 2025年高考英語語法填空熱點(diǎn)語法填空熱點(diǎn)話題06(學(xué)生版+解析)
- 湛江漓源農(nóng)牧科技有限公司年產(chǎn)36萬噸飼料項(xiàng)目環(huán)境影響報(bào)告表
- 隨班就讀試題及答案
- 1.1細(xì)胞是生命活動的基本單位課件高一上學(xué)期生物人教版(2019)必修1
- 2024年福建省長樂市事業(yè)單位公開招聘醫(yī)療衛(wèi)生崗筆試題帶答案
- 食品原料采購與儲存管理協(xié)議
- 市政道路交通導(dǎo)改方案
- 無人機(jī)安全操作試題及答案
- 2025國際服務(wù)貿(mào)易合同范本(中英文)
- 病原學(xué)與防疫技術(shù)體系研究重點(diǎn)專項(xiàng)2025年度項(xiàng)目申報(bào)指南
- 人教版五年級下冊分?jǐn)?shù)加減法簡便計(jì)算300道及答案
評論
0/150
提交評論